Value frameworks

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Note that the structure and content of HemOnc.org are constantly undergoing evolution, such that information that you read here might be outdated. This page was last reviewed and updated in December 2023.

Introduction

Several leading hematology/oncology societies and organizations have put forth value frameworks. Conceptually, these are approaches which are intended to combine measures of efficacy, toxicity, quality of life, and financial toxicity into a metric of value that can be used to influence treatment decisions. Our coverage of value frameworks will expand over time.

ASCO Value Framework

ESCAT

ESMO Magnitude of Clinical Benefit Scale

NCCN Evidence Blocks

Comparisons

ASCO Value Framework vs. ESMO-MCBS

ASCO Value Framework vs. NCCN Evidence Blocks

Frequently asked questions

Q: Do you plan to add value measures to HemOnc.org?
A: At some point in the future, we may add value measures to some regimens; however, given that these frameworks are recently introduced and undergoing frequent revision, we will continue to monitor their development, for now.